Skip to main content

Table 3 Univariate analysis of clinical features and risk score with Cox proportional hazard model

From: Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma

Covariates Overall survival
HR (95%CI)
p Value
Age (< 65 vs. ≥ 65) 1.288 (0.904–1.834) 0.161
Gender (female vs. male) 1.183 (0.823–1.7) 0.363
BMI (< 25 vs. ≥ 25) 1.146 (0.792–1.659) 0.470
Histological grade
 G1 1  
 G2 1.137 (0.67–1.93) 0.634
 G3 1.202 (0.689–2.095) 0.517
 G4 1.641 (0.606–4.442) 0.33
Clinical stage
 Stage I/II 1  
 Stage III/IV 2.463 (1.691–3.589)  < 0.001
T stage
 T1/2 1  
 T3/4 2.594 (1.813–3.710)  < 0.001
AFP (< 300 vs. ≥ 300) 1.018 (0.615–1.685) 0.945
Vascular invasion
 None 1  
 Mico 0.833 (0.519–1.337) 0.449
 Macro 1.284 (0.516–3.193) 0.591
Risk (high vs. low) 2.723 (1.874–3.956)  < 0.001